Uriel Barkai
CSO
Your CSV is on the way
We’ve sent your CSV file to email@email.com
Claimed by
owner Add to list
Beta-O2 Technologies
Former names:
Implantable Bioreactor for Treating Type 1 Diabetes
Stealth Mode
Aug 2025 ceased to operate
Beta-O2 Technologies
Beta-O2 Technologies Overview
Beta-O2 Technologies is a biomedical company developing a proprietary implantable bioreactor, the Air, for the treatment of patients with type 1 diabetes.
The Air is a small medical device that is implanted in a minimally invasive procedure. The device, which contains islets of Langerhans, is intended to free patients from insulin injections and continuous monitoring of glucose levels. The device also reduces the risk of hypoglycemic episodes and other complications of the condition.
Because the Air device contains living cells, the patient needs to refill the air in the device using a replenishing device, which includes a dedicated injector.
The Air is a small medical device that is implanted in a minimally invasive procedure. The device, which contains islets of Langerhans, is intended to free patients from insulin injections and continuous monitoring of glucose levels. The device also reduces the risk of hypoglycemic episodes and other complications of the condition.
Because the Air device contains living cells, the patient needs to refill the air in the device using a replenishing device, which includes a dedicated injector.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Beta-O2 Technologies Climate Tech relevance
null
No Data, yet.
Sorry, no content found under this section.
Mar 16, 2020
www.bioworld.com
Beta-O2 Technologies to begin human trials on new artificial pancreas
undefined
Sep 12, 2019
www.jpost.com
https://www.jpost.com/Israel-News/Hillels-Tech-Corner-Using-tech-to-replicate-the-pancreas-601531
#Investment
Apr 26, 2018
www.diabetes.co.uk
Positive breakthrough made in implanted islet cells technology - Diabetes
#Customers
Dec 3, 2017
www.calcalistech.com
Japanese Technology Holding Company IRI Wants to Raise $30 Million in Tel Aviv IPO
#Public Trading #Investment
Aug 22, 2016
www.globes.co.il
FDA decision boosts Beta-02's artificial pancreas
#Partners
Companies you might be interested in
Driven by Finder AI
Primary sector
Total funding
Funding stage
Number of employees
Founded
Related Content
Lists. Maps. Reports
Team Members
UB
AR
Contact Team
Affiliated Organizations
(null)Web & social links
Locations
Israel
Amal Street 11, Rosh Haayin, Israel
Offices Abroad
Photos & videos
(2)No Data, yet.
Sorry, no content found under this section.
Beta-O2 Technologies Business
Sector
Primary:
Health Tech & Life Sciences
Target Customer
Core Technology
Use Cases
(0)Tech Community Involvement
(0)Beta-O2 Technologies Financials
Cumulative Funding Raised Over Time ($)
No Data, yet.
Sorry, no content found under this section.
Public Offerings & Exits
Private Equity Funding
Undisclosed Round
$25K
Jan 2018
1
Investors
$25K
Undisclosed Round
Undisclosed
Mar 2015
1
Investors
Undisclosed
Undisclosed Round
Undisclosed
Feb 2007
1
Investors
Undisclosed
Seed
$2M
Mar 2004
2
Investors
$2M
Non-Equity Funding
Mergers and Acquisitions
Beta-O2 Technologies Lifecycle
Cumulative Funding Raised Over Time ($)
Timeline
Employees Over Time
News Over Time
No Data, yet.
Sorry, no content found under this section.
Closing Event
Aug 2025
Undisclosed Round
$25K
Jan 2018
1
Investors
$25K
Undisclosed Round
Undisclosed
Mar 2015
1
Investors
Undisclosed
Undisclosed Round
Undisclosed
Feb 2007
1
Investors
Undisclosed
Seed
$2M
Mar 2004
2
Investors
$2M
Beta-O2 Technologies News
News Over Time
No Data, yet.
Sorry, no content found under this section.
News Articles
Mar 16, 2020
www.bioworld.com
Beta-O2 Technologies to begin human trials on new artificial pancreas
undefined
Sep 12, 2019
www.jpost.com
https://www.jpost.com/Israel-News/Hillels-Tech-Corner-Using-tech-to-replicate-the-pancreas-601531
#Investment
Apr 26, 2018
www.diabetes.co.uk
Positive breakthrough made in implanted islet cells technology - Diabetes
#Customers
Dec 3, 2017
www.calcalistech.com
Japanese Technology Holding Company IRI Wants to Raise $30 Million in Tel Aviv IPO
#Public Trading #Investment
Aug 22, 2016
www.globes.co.il
FDA decision boosts Beta-02's artificial pancreas
#Partners
Related Content
Beta-O2 Technologies Team
No Data, yet.
Sorry, no content found under this section.
Employees Over Time
Companies you might be interested in
Driven by Finder AI
Beta-O2 Technologies Internal
Create note
Notes
(undefined)
Filter notes
Content Writer
undefined
BI Verification
undefined
Phone Number
undefined
Israel Register ID
undefined
Confidence Score
undefined
Missing Fields
undefined
Profile Creator
undefined
Profile Update
undefined
undefined
Access Comprehensive Financial Analytics
Create a free account to:
- Explore detailed financial analytics.
- Track company growth and size.
- Connect with company team members.
I already have access,
I already have access,